Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current Knowledge and Future Directions

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-139x|29|5|374-381

ISSN： 0894-0959

Source： SEMINARS IN DIALYSIS, Vol.29, Iss.5, 2016-09, pp. : 374-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: From the Research Laboratory to the Clinic and Vice Versa

By  

Cardiology, Vol. 127, Iss. 4, 2014-01 ,pp. : 211-219

Karger

Access to resources Recommend Favorite

Isolation and Characterization of Human Coronary Artery-Derived Endothelial Cells in vivo from Patients Undergoing Percutaneous Coronary Interventions

By  

Journal of Vascular Research, Vol. 46, Iss. 5, 2009-02 ,pp. : 487-494

Karger

Access to resources Recommend Favorite

Prevalence of Chronic Kidney Disease in Elderly Patients with Normal Serum Creatinine Levels Undergoing Percutaneous Coronary Interventions

By  

Gerontology, Vol. 56, Iss. 1, 2009-12 ,pp. : 51-54

Karger

Access to resources Recommend Favorite

Clinical Outcomes Comparing Eptifibatide and Abciximab in ST Elevation Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions

By  

Cardiology, Vol. 107, Iss. 3, 2006-08 ,pp. : 172-177

Karger

Access to resources Recommend Favorite

Clinical Potential of Oral Nicorandil to Improve Myocardial Fatty Acid Metabolism after Percutaneous Coronary Intervention in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 126, Iss. 1, 2014-01 ,pp. : 24-32

Karger

Access to resources Recommend Favorite